Gaining over 15,000 cases this 2024 and leading with the lowest survival rate for cancer types, lung cancer has been in the forefront of cancer cases in Australia. Biomarkers such ALK, ROS1, PD-L1, and BRAF are used in IHC and molecular laboratory techniques to identify specific types of lung cancer and guide targeted therapy.
Are you looking into standardising QC in your lung IHCs? Try our HistoCyte cell-line Dynamic Range (DR) and Standard control blocks*:
- ALK Analyte
- ROS1 Analyte
- PD-L1 Analyte
- BRAF Analyte
ALK Analyte ControlDR
A cost-effective solution for high volume centres. The cell microarray blocks contain 4 key cores: Breast adenocarcinoma, Glioblastoma, Lung adenocarcinoma, and Anaplastic large cell lymphoma.
| Cell line | IHC for ALK-EML4 (Lung) | IHC for ALK-NPM (Lymphoma) | FISH for ALK |
| A | Negative | Negative | Negative |
| B | Low | Negative | Negative |
| C | High | Mid | Positive |
| D | High | High | Positive |
ROS1 Analyte Control DR
Purposely designed to fit seamlessly into the work flow of the laboratory. The cell microarray blocks contain 3 key cores: Breast adenocarcinoma, Glioblastoma, and Lung adenocarcinoma.
| Cell line | IHC for ROS1 | FISH for ROS1 translocation |
| A |
Negative |
Negative |
| B |
Low |
Positive (deletion) FIG-ROS1 |
| C | High | Positive SCL34A2-ROS1 |
Learn more about HistoCyte
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
* All products show on this page are for Research Use Only (RUO)
